Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELID1 pseudogene 3 (PRELID1P3) is a human pseudogene, meaning it is a non-functional sequence related to the PRELID1 gene, which encodes a mitochondrial protein involved in phospholipid transfer and cell death regulation[7][1][4]. No evidence exists that PRELID1P3 encodes a functional protein product or is involved in key biological processes or disease mechanisms. Unlike some pseudogenes shown to have regulatory RNA functions, there is no specific data for PRELID1P3 in the literature or genetic databases; its entry in databases such as the Alliance Genome Resources confirms only its status as a pseudogene without functional annotation[7]. Therefore, PRELID1P3 is not considered a druggable therapeutic target and should not be confused with PRELID1 or other functional PRELID1-related pseudogenes that may have roles in human disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELID1 pseudogene 3 (PRELID1P3).